It seems probable that in the last 10years, forecasting the weather has become more accurate than giving a prognosis on a particular patient. The reason for the improved accuracy is that much more weather data can be obtained quickly and analysed by computer. What is happening in medicine? Knowledge about the death rate of a disease has been obtained from death certification figures which are subject to serious errors and from experience passed on by teachers. Few would doubt the value of experience, either general or specialist, although at times the greatest of teachers has been wrong: in 1898 William Osler! wrote of asthma, 'death during the attack is unknown'; the harsh truth is that in England and Wales 1500 asthmatics die each year", The death rates of a disease can sometimes change dramatically; for example, that of infective endocarditis in the UK has fallen from 900 in 1943 to 200 in 1983 3 • However, the death rate of a disease or condition is oflittle relevance to the individual patient unless the disease is never fatal or invariably so. What is relevant is the predicted outcome for the individual observed as soon as possible after the onset of the illness. Research into this problem has produced valuable results obtained in acute diseases. These predictors of outcome are of two main types -global or specific to a disease. The best example of the former is the APACHE II scale from Washington DC4, a system derived from data obtained on nearly 6000 patients treated at 13 hospitals. To apply APACHE II requires 12 physiological measurements (acute physiological assessment: APA) made during the first 24 hours. These include heart rate, arterial blood pressure, the universally used Glasgow Coma Scale" and serum chemistry; the 'worst' result is the one used to obtain the score. The patient's age is included, which is not surprising as this has long been known to influence the outcome of critical illnesses. The remaining part of the system is chronic health evaluation (CHE). This takes account of severe preexisting disease of the liver, heart, lungs or kidneys and the immune status of the patient. Finally, operative surgery, elective or emergency, is incorporated. The main use of the APACHE system is to 'prognostically stratify acutely ill patients". In addition, it allows comparisons to be made between different hospitals and between old and new treatments. The accuracy on an individual patient basis is less well defined, but the system provides a valuable aid to decision-making.
Consider now the acute failure of one organ -the brain. Can the clinician read the crystal ball in coma without computerized axial tomography or other high technology? Prospective studies have shown that in the past observer errors made a mockery ofthe assessment", but accuracy is forthcoming. A milestone was reached in 1974when Teasdale and Jennett described the Glasgow Coma Scale'' which has been adapted worldwide. At long last simple examination ofthe motor and verbal responses and of eye-opening produced a dependable score for monitoring states of coma and impaired consciousness. Its systematic application has given us some predictors of outcome of surprising accuracy. Consider non-traumatic coma, usually due to a 'cerebrovascular accident' and less commonly metabolic such as hepatic encephalopathy. Levy et at. studied 500 patients with nontraumatic coma admitted to three hospitals 7 • The mean age was 59 years and this did not prove to be a factor determining outcome. The study lasted one year and any recovery was given one of four grades: from good recovery to a vegetative state. This system reduces observer error and deserves to be widely adopted. Only 15 of the 500 patients made a good recovery. The research was of great value because even on the first day of observation the outcome at one year could be predicted with surprising accuracy. These predictions required only the Glasgow Coma Assessment and the corneal, pupillary and caloric responses; it was important not to depend on a single sign. Many of the 500 patients were treated in American intensive care units, which was very expensive, and whilst this therapy may have prolonged the life of some, the outcome at one year was probably similar to that in patients given less aggressive and much cheaper care. The implications, both humanistic and economic, are obvious.
When a disease has a high mortality despite all the expensive therapies of high technology medicine, then predictors of outcome are essential for 'humanitarian benefits and economics". The death rate of adult respiratory distress syndrome (ARDS) is about 50% 8 , whether treated in Newcastle, Washington DC or Sydney, and recently Smith and Gordon? have described an accurate predictor of outcome which should help those who care for these patients in intensive care units. The ventilator score they devised requires information which is invariably available for patients with ARDS -age, the upper airway pressure and the alveolar-arterial oxygen gradient. A simple calculation then gives the ventilator score: a value below 80indicates that the lung lesion is reversible, and a value above 80 signifies irreversibility and a fatal outcome. This ventilator score has the two essential features of predictors -accuracy and simplicity.
Of the 8000 patients who each month have an acute myocardial infarction J 0, approximately 40% reach hospital alive!", In such a common condition with a mortality of 20% J 2, one would expect accurate predictors of outcome. Certainly the research got off to an early start and the 'Peel index' was published in 1962, but did not last long!3. Subsequent predictors have been of two kinds. The first is based on clinical features and the electrocardiograph (ECG); the second depends on haemodynamic monitoring. A good example of the former was published from Auckland in 1969 14 • The variables which determined outcome were age, ECG signs, systolic blood pressure on 0141-0768/87/ 030133-02/$02.00/0 e 1987 The Royal Society of Medicine admission, heart size, grade of pulmonary oedema and history of previous ischaemia. The calculations required to obtain the coronary prognostic index were very simple. An index of less than 4 predicted a death rate of3% and at the other extreme an index of more than 12 implied a death rate of 78%. It might be expected that such a dependable predictor would be widely used in coronary care, but this is not the case. Physicians seem reluctant to analyse data on the individual patient at the bedside and prefer to apply mortality statistics; for example, cardiogenic shock has a death rate of 80% 1 S and less than half of those who have a cardiac arrest will walk out of'hospital!".
Turning next to haemodynamics, such measurements were necessary to unravel the circulatory changes that can follow cardiac infarction11. Have such measurements given us predictors which are many times better than the noninvasive predictors? For coronary care as a whole the answer is no, because the correlations between outcome and physiological data were limited to those patients in shock; in this subset the stroke index was. the most accurate predictor l s • 19 , but no more so than the arterial blood lactate'" or the skin temperaturejP. Given these results it would be difficult in the UK to justify haemodynamic monitoring following acute myocardial infarction other than for research.
Can we draw any conclusions about the value of predictions of outcome? The short answer is that we already have accurate predictors and many more will follow, but we must be prepared to use them; the images in the crystal ball are becoming clearer.
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A coronary prognostic index for grading the severity of infarction. The results of epidemiological studies of schizophrenia, using designs and methodology that meet reasonably satisfactory scientific criteria, have not consistently revealed any causes other than a clear-cut, but small, and so far nonspecific genetic predisposition. A consistent, but unexplained, finding is the characteristic pattern of incidence by age and sex. Schizophrenia begins earlier and runs a more severe course in men than in women, although the overall incidence is the same. A third, regularly observed phenomenon is that people who later become schizophrenic tend to be born during the winter months. Although the effect is very small, it has been fairly consistently observed in both hemispheres, suggesting a predisposition due to fetal or neonatal damage. Most of the other epidemiological regularities, such as the association with lower than expected occupational or social or marital status, or with various patterns of migration, or with membership of markedly different cultural groups, seem to be explicable largely as effects of the disorder rather than as causes.
Hare", in his careful review of these studies, remarked that precision in diagnosis was not essential for epidemiological progress, pointing to the examples of dementia paralytica and pellagra. It could be argued, however, that the discovery of a strong causative factor in each case made diagnostic precision less important. No such factor has emerged in studies of schizophrenia. It may yet do so, of course, but if there are multiple causes, each of small effect, the differences between schools demonstrated by the US-UK studies and the International Pilot Study of Schizophrenia' are likely to hinder their discovery. Fortunately, both studies showed that, by using a standard method of clinical assessment
